The Renin-Angiotensin System Revisited: Classical and Nonclassical Pathways of Angiotensin Formation

Mount Sinai Journal of Medicine

Volumn 65, Issue 2, 1998, Pages 87-96

  Atlas, Steven A ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Angiotensin; Angiotensin converting enzyme; Angiotensinogen; Autocrine; Cathepsins; Chymase; Endocrine; Paracrine; Renin

Indexed keywords

ANGIOTENSIN II;

ANIMAL; BIOSYNTHESIS; HUMAN; KIDNEY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; HUMANS; KIDNEY; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032011007     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system. In: Windhager EE, editor. Handbook of Physiology, section 8, Renal Physiology. New York: Oxford University Press, 1992. p. 1409-1541.
2. Pfeffer MA, Lamas GA, Vaughn DE, et al. Effect of captopril on progressive ventricular dilation after anterior myocardial infarction. N Engl J Med 1988; 319:80-86.
3. Pfeffer M, Braunwald E, Boye L, The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992; 327:669-677.
4. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327:685-691.
5. Linz W, Scholkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 1989; 11:1325-1350.
6. DeSchepper CF, Mellon SH, Cumin F, et al. Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal and pituitary of the rat. Proc Natl Acad Sci USA 1986; 83: 7552-7556.
7. Sealey JE, Atlas SA, Laragh JH. Prorenin and other large molecular weight forms of renin. Endocr Rev 1980; 1:365-391.
8. Atlas SA, Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system and atrial natriuretic factor. In: Schneiderman N, Weiss SM, Kaufmann PG, editors. Handbook of Research Methods in Cardiovascular Behavioral Medicine. New York: Plenum Publishing Corp, 1989 p. 237-257.
9. Sealey JE, White RP, Laragh JH, Rubin AL. Plasma prorenin and renin in anephric patients. Circ Res 1977; 41(suppl 2):17-21.
10. Doolittle RF. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science 1983; 222:417-419.
11. Tewksbury DA, Dart RA, Travis J. The amino terminal amino acid sequence of human angiotensinogen. Biochem Biophys Res Commun 1981; 99:1311-1315.
12. Lynch KR, Peach MJ. Molecular biology of angiotensinogen. Hypertension 1991; 17:263-269.
13. Campbell DJ, Habener JF. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J Clin Invest 1986; 78:31-38.
14. Vander AJ, Geelhoed GW. Inhibition of renin secretion by angiotensin II. Proc Soc Exp Biol Med 1965; 120: 399-403.
15. Menard J, El-Amrani AIK, Savoie F, Bouhnik J. Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension 1991; 18:705-706.
16. Erdos EG, Skidgel RA. The unusual substrate specificity and the distribution of human angiotensin I converting-enzyme. Hypertension 1986; 8(suppl 1):34-37.
17. Ryan JW, Ryan US, Schultz DR, et al. Subcellular localization of angiotensin-converting enzyme (kininase II). Biochem J 1975; 146:497-499.
18. Ng KKF, Vane JR. Conversion of angiotensin I to angiotensin II. Nature 1967; 215:762-766.
19. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF. Non-peptide angiotensin-II receptor antagonists. Trends Pharmacol Sci 1991; 12:55-62.
20. Sumners C, Tang W, Zelezna B, Raizada MK. Angiotensin-II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA 1991; 88:7567-7571.
21. Dzau VJ. Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 1987; 77(suppl 4A):31-36.
22. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77(suppl 1):I-4-I-13.
23. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system: an appraisal of present experimental and clinical evidence. Circ Res 1991; 68:905-921.
24. Paul M, Bachmann J, Ganten D. The tissue renin-angiotensin systems in cardiovascular disease. Trends Cardiovasc Med 1992; 2:94-99.
25. von Lutterotti N, Catanzaro DF, Sealey JE, Laragh JH. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 1994; 89:458-470.
26. Dzau VJ, Re R. Tissue angiotensin system in cardiovascular medicine. A paradigm shift? Circulation 1994; 89:493-498.
27. Danser AH, Koning MM, Admiraal PJ, et al. Production of angiotensins I and II at tissue sites in intact pigs. Am J Physiol 1992; 263:H429-H437.
28. Danser AH, Koning MM, Admiraal PJ, et al. Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol 1992; 263:H418-H428.
29. Admiraal PJ, Danser AH, Jong MS, et al. Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993; 21:173-184.
30. Gould AB, Skeggs LT, Kahn JR. The presence of renin activity in blood vessel walls. J Exp Med 1964; 119: 389-399.
31. Ganten D, Schelling P, Vecsei P, Ganten U. Iso-renin of extra-renal origin: the tissue angiotensinogenase systems. Am J Med 1976; 60:760-772.
32. Hirose S, Yokosawa H, Inagami T, Workman RJ. Renin and prorenin in hog brain: ubiquitous distribution and high concentration in the pituitary and pineal. Brain Res 1980; 191:489-499.
33. Dzau VJ, Brennar A, Emmett NL. Evidence for renin in rat brain: differentiation from other renin-like enzymes. Am J Physiol 1982; 242:E292-E297.
34. Mizuno K, Ogima M, Hashimoto S. Multiple forms of immunoreactive renin in human pituitary tissue. Lite Sci 1985; 37:2297-2304.
35. Warren AY, Craven DJ, Symonds EM. Production of active and inactive renin by cultured explants from human female genital tract. Br J Obstet Gynaecol 1982; 89:628-632.
36. Dzau VJ, Gonzalez D, Ellison K, et al. Characterization of purified rabbit uterine renin: influence of pregnancy on uterine inactive renin. Endocrinology 1987; 120: 358-364.
37. Lenz T, Sealey JE, August P, et al. Tissue levels of active and total renin, angiotensinogen, hCG, estradiol and progesterone in human placentas from different methods of delivery. J Clin Endocrinol Metab 1989; 69:31-37.
38. Naruse M, Takii Y, Inagami T. Renin exists in high concentration in the adrenal gland of the rat. Biomed Res 1981; 2:583-586.
39. Naruse M, Sussman CR, Naruse K, et al. Renin exists in human adrenal tissue. J Clin Endocrinol Metab 1983; 57:482-487.
40. Thurston H, Swales JD, Bing RF, et al. Vascular renin-like activity and blood pressure maintenance in the rat: studies of the effect of changes in sodium balance, hypertension and nephrectomy. Hypertension 1979; 1:643-649.
41. Fordis CM, Megorden JS, Ropchak RG, Keiser HR. Absence of renin-like activity in rat aorta and microvessels. Hypertension 1983; 5:635-641.
42. Swales JD, Abramovici A, Beck F, et al. Arterial wall renin. J Hypertens 1983; 1(suppl 1):17-22.
43. Loudon M, Bing RF, Thurston H, Swales JD. Arterial wall uptake of renal renin and blood pressure control. Hypertension 1983; 5:629-634.
44. Re R, Fallon JT, Dzau V, et al. Renin synthesis by canine aortic smooth muscle cells in culture. Life Sci 1982; 30:99-106.
45. Ohashi H, Matsunaga M, Kuwahara T, et al. Production and release of inactive renin by human smooth muscle cells. Clin Exp Hypertens 1985; A7:1395-1407.
46. Lilly LS, Pratt RE, Alexander RW, et al. Renin expression by vascular endothelial cells in culture. Circ Res 1985; 57:312-318.
47. Dzau VJ, Ellison KE, Brody T, et al. A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology 1987; 120:2334-2338.
48. Paul M, Wagner D, Metzger D, et al. Quantification of renin mRNA in various tissues by a novel solution hybridization assay. J Hypertens 1988; 6:247-252.
49. Ekker M, Tronik D, Rougeon F. Extra-renal transcription of the renin genes in multiple tissues of mice and rats. Proc Natl Acad Sci USA 1989; 86:5155-5158.
50. Tada M, Fukamizu A, Seo MS, et al. Renin expression in the kidney and brain is reciprocally controlled by captopril. Biochem Biophys Res Commun 1989; 158:1065-1071.
51. Field LJ, McGown RA, Dickinson DP, Groww KW. Tissue and gene specificity of mouse renin expression. Hypertension 1984; 6:597-603.
52. Holycross BJ, Saye JA, Harrison JK, Peach MJ. Polymerase chain reaction analysis of renin in rat aortic smooth muscle. Hypertension 1992; 19:697-701.
53. Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 1995; 92:2690-2696.
54. Dostal DE, Baker KM. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Medication by the AT1 receptor. Am J Hypertens 1992; 5:276-280.
55. Okura T, Kitami Y, Iwata T, Hiwada K. Quantitative measurement of extra-renal renin mRNA by polymerase chain reaction. Biochem Biophys Res Commun 1991; 179:25-31.
56. Sealey JE, Moon C, Laragh JH, Atlas SA. Plasma prorenin in normal, hypertensive, and anephric subjects and its effect on renin measurements. Circ Res 1977; 40(suppl 1):I-41-I-45.
57. Pandey KN, Melner MH, Parmentier M, Inagami T. Demonstration of renin activity in purified rat Leydig cells. Evidence for the existence of an endogenous inactive (latent) form of enzyme. Endocrinology 1984; 115:1753-1759.
58. Lumbers ER. Activation of renin in human amniotic fluid by low pH. Enzymologia 1971; 40:329-336.
59. Glorioso N, Atlas SA, Laragh JH, et al. Prorenin in high concentrations in human ovarian follicular fluid. Science 1986; 233:1422-1424.
60. Ohkubo H, Nakayama K, Tanaka T, Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem 1986; 261:319-323.
61. Schunkert H, Ingelfinger JR, Jacob H, et al. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 1992; 263:E863-E869.
62. Schunkert H, Ingelfinger JR, Hirsch AT, et al. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 1992; 90:1523-1529.
63. Lindpaintner K, Lu W, Niedermajer N, et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. J Mol Cell Cardiol 1993; 25:133-143.
64. Milsted A, Nishimura M, Brosnihan B, Ferrario C. Differential regulation of angiotensinogen transcripts after renin infusion. Hypertension 1996; 28:678-681.
65. Seikaly MG, Arant BS, Seney F. Endogenous angiotensin concentration in specific intrarenal fluid compartments. J Clin Invest 1990; 86:1352-1357.
66. Hunt MK, Ramos SP, Geary KM, et al. Colocalization and release of angiotensin and renin in renal cortical cells. Am J Physiol 1992; 263:F363-F373.
67. Wallis CJ, Printz MP. Adrenal regulation of regional brain angiotensinogen content. Endocrinology 1980; 106:337-342.
68. Lippoldt A, Paul M, Fuxe K, Ganten D. The brain renin-angiotensin system: molecular mechanisms of cell to cell interactions. Clin Exp Hypertens 1995; 17:251-266.
69. Cushman DW, Cheung HS. Concentration of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 1971; 250:261-265.
70. Sibony M, Gasc JM, Soubrier F, et al. Gene expression and tissue localization of the two isoforms of the angiotensin I converting enzyme. Hypertension 1993; 21: 827-835.
71. Yang H-YT, Neff NH. Distribution and properties of angiotensin-converting enzyme of rat brain. J Neurochem 1972; 19:2443-2450.
72. Wigger HJ, Stalcup SA. Distribution and development of angiotensin-converting enzyme in the fetal and newborn rabbit. An immunofluorescence study. Lab Invest 1978; 38:581-585.
73. El-Dorry HA, Bull HG, Iwata K, et al. Molecular and catalytic properties of rabbit testicular dipeptidyl carboxypeptidase. J Biol Chem 1982; 257:14128-14133.
74. El-Dorry HA, Pickett CB, McGregor JA, Soffer RL. Tissue-specific expression of mRNAs for dipeptidyl carboxypeptidase isoenzymes. Proc Natl Acad Sci USA 1982; 79:4295-4297.
75. Schunkert H, Dzau VJ, Tang SS, et al. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility and relaxation. J Clin Invest 1990; 86:1913-1920.
76. Hirsch AT, Talsness CE, Schunkert H, et al. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991; 69:475-482.
77. Guan S, Fox J, Michell KD, Navar LG. Angiotensin and angiotensin converting enzyme tissue levels in two kidney, one clip hypertensive rats. Hypertension 1992; 20:763-767.
78. Malik KU, Nasjletti A. Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res 1976; 38:26-30.
79. Oliver JA, Sciacca RR. Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 1984; 6:1247-1251.
80. Sybertz EJ, Ahn HS, Baum T, et al. Mechanisms of the pressor response to tetradecapeptide renin substrate in the rat. Clin Exp Hypertens 1984; A6:2143-2159.
81. Ziogas J, Story DF. Effects of tetradecapeptide renin substrate on isolated preparations of rat caudal artery. Clin Exp Pharmacol Physiol 1986; 13:271-276.
82. Nakamaru M, Inagami T, Ohigara T, Kumahara Y. Effect of captopril on angiotensin II release from vascular tissue. Clin Exp Hypertens 1987; A9:477-480.
83. Juul B, Aalkjaer C, Mulvany MJ. Contractile effects of tetradecapeptide renin substrate on rat femoral resistance vessels. J Hypertens 1987; 5(suppl 2):S7-S10.
84. Mizuno K, Nakamura M, Higashimori K, Inagami T. Local generation and release of angiotensin II in peripheral vascular tissue. Hypertension 1988; 11:223-229.
85. Kato H, Iwai N, Inul H, et al. Regulation of vascular angiotensin release. Hypertension 1993; 21:446-454.
86. Fishman MC, Zimmerman EA, Slater EE. Renin and angiotensin. The complete system within the neuroblastoma X glioma cell. Science 1981; 214:921-923.
87. Okamura T, Clemens DL, Inagami T. Renin, angiotensins and angiotensin-converting enzyme in neuroblastoma cells. Evidence for intracellular formation of angiotensins. Proc Natl Acad Sci U S A 1981; 78:6940-6943.
88. Pickel VM, Chan J, Ganten D. Dual peroxidase and colloidal gold-labelling study of angiotensin-converting enzyme and angiotensin-like immunoreactivity in the rat subfornical organ. J Neurosci 1986; 6:2457-2469.
89. Saint-Andre J-P, Rohmer V, Alhenc-Gelas F, et al. Presence of renin, angiotensinogen, and converting enzyme in human pituitary lactotroph cells and prolactin adenomas. J Clin Endocrinol Metab 1986; 63:231-237.
90. Cook JL, Chen L, Bhandaru S, et al. The use of antisense oligonucleotides to establish autocrine angiotensin growth effects in human neuroblastoma and mesangial cells. Antisense Res Dev 1992; 2:199-210.
91. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 977-984.
92. Hackenthal E, Hackenthal R, Hilgenfeldt U. Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes. Biochim Biophys Acta 1978; 522:574-588.
93. Ganten D, Ganten U, Schelling P, et al. The renin-and iso-renin-angiotensin systems in rats with experimental pituitary tumors. Proc Soc Exp Biol Med 1975; 148: 568-572.
94. Husain A, Smeby R, Wiek D, et al. Biochemical and immunological properties of dog brain isorenin. Endocrinology 1984; 114:2210-2215.
95. Boucher R, Asselin JH, Genest J. A new enzyme leading to direct formation of angiotensin II. Circ Res 1974; 34(suppl 1):I-203-I-209.
96. Wintroub BU, Klickstein LB, Watt KW. A human neutrophil dependent pathway for generation of angiotensin II. J Clin Invest 1981; 68:484-490.
97. Klickstein LB, Kaempfer CE, Wintroub BU. The granulocyte angiotensin system. Angiotensin I converting activity of cathepsin G. J Biol Chem 1982; 357:1504-1506.
98. Wintroub B, Klickstein LB, Dzau VJ, Watt KWK. Granulocyte-angiotensin system. Identification of angiotensinogen as substrate of leukocytes cathepsin G. Biochemistry 1984; 23:227-232.
99. Yamaguchi T, Carretero OA, Scicli AG. A novel serine protease with vasoconstrictor activity coded by the kallikrein gene S3. J Biol Chem 1991; 266:5011-5017.
100. Moreau T, Brillard-Bourdet M, Bouhnik J, Gauthier F. Protein products of the rat kallikrein gene family. Substrate specificities of kallikrein rK2 (tonin) and kallikrein rK9. J Biol Chem 1992; 267:10045-10051.
101. Wang C, Tang CQ, Zhou GX, et al. Biochemical characterization and substrate specificity of rat prostate kallikrein (S3): comparison with tissue kallikrein, tonin and T-kininogenase. Biochim Biophys Acta 1992; 1121:309-316.
102. Tang SS, Loscalzo J, Dzau VJ. Tissue plasminogen activator activates renin angiotensin in vitro. J Vasc Med Biol 1989; 1:67-74.
103. Okunishi H, Miyazaki M, Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 1984; 2:277-284.
104. Okunishi H, Miyazaki M, Okamura T, Toda N. Different distributions of two types of angiotensin II-generating enzymes in the aortic wall. Biochem Biophys Res Commun 1987; 149:1186-1192.
105. Urata H, Kinoshita A, Misono KS, et al. Identification of a highly specific chymase as the major angiotensin-II-forming enzyme in the human heart. J Biol Chem 1990; 265:22348-22357.
106. Urata H, Healy B, Stewart RW, et al. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990; 66:883-890.
107. Urata H, Hoffmann S, Ganten D. Tissue angiotensin II system in the human heart. Eur Heart J 1994; 15(suppl D):68-78.
108. Mangiapane ML, Rauch AL, MacAndrew JT, et al. Vasoconstrictor action of angiotensin I-convertase and the synthetic substrate (Pro11,D-Ala12)-angiotensin I. Hypertension 1994; 23:857-860.
109. Holt BD, Shao Y, Kinoshita A, et al. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon. J Clin Invest 1995; 95:1519-1527.
110. Cambien F, Poirier O, Leceft L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644.
111. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction. Clin Genet 1994; 46:94-101.
112. Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995; 92:1387-1388.
113. Ueda S, Elliott HL, Morton JJ, Connell JM. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995; 25:1266-1269.
114. Lachurie ML, Azizi M, Guyene TT, et al. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995; 91:2933-2942.